免疫組織化学の世界市場予測（～2021）：抗体、試薬、キット、スライド染色装置、組織マイクロアレイ...市場調査レポートについてご紹介

1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Immunohistochemistry Market Definition
1.3 Immunohistochemistry Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 23)
2.1 Research Approach
2.2 Immunohistochemistry Market Size Estimation
2.3 Immunohistochemistry Market Breakdown and Data Triangulation
2.4 Immunohistochemistry Market Share Estimation
2.4.1 Secondary Sources
2.4.1.1 Key Data From Secondary Sources
2.4.2 Primary Sources
2.4.2.1 Key Data From Primary Sources
2.4.3 Key Industry Insights
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 34)
4.1 Immunohistochemistry: Market Overview
4.2 Immunohistochemistry Market Size, By Product, 2016 vs 2021
4.3 Geographic Snapshot of the Immunohistochemistry Market (2015)
4.4 Immunohistochemistry Market: Geographic Mix
4.5 Immunohistochemistry Market: Developing vs Developed Countries (2016-2021)

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Key Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Prevalence of Cancer
5.2.1.2 Rapidly Increasing Geriatric Population
5.2.1.3 Rapid Technological Developments in the Ivd Industry
5.2.1.4 Increasing Healthcare Spending
5.2.2 Market Restraints
5.2.2.1 Limited Reimbursements
5.2.2.2 Implementation of Excise Duty By the U.S. Government
5.2.3 Market Opportunities
5.2.3.1 Rapid Growth in the Emerging Markets of APAC and Latin America
5.2.3.2 Increasing Demand for Personalized Medicine
5.2.4 Market Challenge
5.2.4.1 Regulatory Restrictions

6 Industry Insights (Page No. – 46)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Consolidation of the Immunohistochemistry Market
6.2.2 Incorporation of Nanotechnology in Immunohistochemistry
6.2.3 Adoption of Multiplex Arrays
6.2.4 Automation in Immunohistochemistry Market
6.3 Regulatory Analysis
6.3.1 North America
6.3.2 Europe
6.3.3 Asia-Pacific

7 Global Immunohistochemistry Market, By Product (Page No. – 53)
7.1 Introduction
7.2 Antibodies
7.2.1 Primary Antibodies
7.2.2 Secondary Antibodies
7.3 Equipment
7.3.1 Slide Staining Systems
7.3.2 Tissue Microarrays
7.3.3 Tissue Processing Systems
7.3.4 Slide Scanners
7.3.5 Other Equipment
7.4 Reagents
7.4.1 Histological Stains
7.4.2 Blocking Sera and Reagents
7.4.3 Chromogenic Substrates
7.4.4 Fixation Reagents
7.4.5 Stabilizers
7.4.6 Organic Solvents
7.4.7 Proteolytic Enzymes
7.4.8 Diluents
7.5 Kits

8 Global Immunohistochemistry Market, By Application (Page No. – 78)
8.1 Introduction
8.2 Diagnostics
8.2.1 Cancer
8.2.2 Infectious Diseases
8.2.3 Cardiovascular Disease
8.2.4 Autoimmune Diseases
8.2.5 Diabetes Mellitus
8.2.6 Nephrological Diseases
8.3 Drug Testing

9 Global Immunohistochemistry Market, By End User (Page No. – 90)
9.1 Introduction
9.2 Hospitals and Diagnostic Laboratories
9.3 Research Institutes
9.4 Other End Users

10 Global Immunohistochemistry Market, By Region (Page No. – 96)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.2 Middle East and Africa

11 Competitive Landscape (Page No. – 165)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situations and Trends
11.3.1 Product Launches
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Acquisitions
11.3.4 Expansions

12 Company Profiles (Page No. – 172)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 F. Hoffmann-LA Roche AG
12.3 Danaher Corporation
12.4 Agilent Technologies, Inc.
12.5 Thermo Fisher Scientific Inc.
12.6 Merck Millipore
12.7 Bio-Rad Laboratories, Inc.
12.8 Perkinelmer, Inc.
12.9 Abcam PLC
12.10 Cell Signaling Technology, Inc.
12.11 Bio SB

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 207)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details